Johannes Franciscus Diependaal
Direttore/Membro del Consiglio presso Insmed Innovation UK Ltd.
Provenienza dei contatti di primo grado di Johannes Franciscus Diependaal
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Johannes Franciscus Diependaal tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
The University of Edinburgh | College/University | Doctorate Degree | |
KuDOS Pharmaceuticals Ltd.
KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Cambridge | College/University | Corporate Officer/Principal | |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
Regno Unito | 6 |
Stati Uniti | 2 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Miscellaneous | 2 |
Commercial Services | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Doctorate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Stephen Jackson | 6 |
Robert Johnson | 2 |
Jamie Sale | 1 |
- Borsa valori
- Insiders
- Johannes Franciscus Diependaal
- Connessioni Società